PharmaTalks - Nitrosamines
- Start 9 Maggio 2024, 11:00
- End 9 Maggio 2024, 12:30
LabAnalysis Group is proud to announce the launch of PharmaTalks, an innovative webinar series aimed at addressing the evolving challenges within the global pharmaceutical market. Discover the full programme!
What will we talk about?
Nitrosamines, chemical compounds classified as probable carcinogens by the International Agency for Research on Cancer, have become a crucial topic in the pharmaceutical industry.
Since 2018, the FDA and EMA have set maximum limits for the presence of nitrosamines in pharmaceutical products, recognising the carcinogenic risk associated with their presence.
The first 2024 meeting will be held:
Thursday 9 May, 11:00 a.m. - 12:30 p.m.
Nitrosamines
Our esteemed panel of experts will navigate through the regulatory frameworks established by the EMA and FDA, offering insights into quality control measures and cutting-edge analytical techniques crucial for Nitrosamine detection.
In detail, we will discuss about:
- EMA and FDA regulatory regulations
- Advanced analytical techniques for the determination of nitrosamines
- Special case studies in LC-MS and GC-MS
- Enhanced Ames Test for nitrosamines
This exclusive webinar, conducted entirely in English via Zoom, presents a rare opportunity to engage with industry leaders at absolutely no cost.
Secure your spot today, sign up now!
Further information
info@labanalysis.it